Stockscreener 앱 받기
20.66
1.90%
-0.40
시간 외 거래:
20.66
Innoviva Inc 주식(INVA)의 최신 뉴스
Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026 - Stock Titan
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
INVA vs. MRK: Which Stock Is the Better Value Option? - Zacks Investment Research
5 Attractive Low Price-to-Sales Stocks With Promising Upside Potential - Zacks Investment Research
Should Value Investors Buy Innoviva (INVA) Stock? - Zacks Investment Research
Understanding Momentum Shifts in (INVA) - Stock Traders Daily
Innoviva at Cantor conference: growth bets beyond COPD royalties - investing.com
Innoviva at Cantor conference: growth bets beyond COPD royalties By Investing.com - Investing.com India
INVA - Finviz
Innoviva to Participate in Upcoming September 2026 Investor Conferences - biospace.com
Innoviva to Participate in Upcoming Investor Conferences - finance.yahoo.com
INVA Q2 2026 Earnings: EPS Misses by 356% as Loss Hits $1.14Consensus Forecast Report - vinanet.vn
(INVA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Entasis Therapeutics Holdings Inc. (ETTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Innoviva CEO Pavel Raifeld Executes Tax-Related Share Withholding Transaction - Kalkine Media
Innoviva (NASDAQ: INVA) CFO now holds 88,013 shares after tax withholding - Stock Titan
Innoviva (NASDAQ: INVA) CEO sees 1,130 shares withheld for taxes - Stock Titan
Innoviva CFO Stephen Basso Reports Share Withholding Transaction to Cover Taxes on August 2026 Equity Vesting - Kalkine Media
Cantor Fitzgerald reiterates Innoviva stock rating at overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Innoviva stock rating at overweight - Investing.com
Cantor Fitzgerald reiterates Innoviva stock rating at overweight By Investing.com - Investing.com UK
NewEdge Wealth LLC Acquires New Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - vinanet.vn
Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - dars.gov.et
70,000 Shares in Innoviva, Inc. $INVA Purchased by Chase Investment Counsel Corp - MarketBeat
Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
Innoviva, Inc.: Target Price Consensus and Analysts Recommendations | INVA | US45781M1018 - marketscreener.com
Bank of America Corp DE Has $37.75 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSuperTrend - vinanet.vn
Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSupply Zone - dars.gov.et
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo! Finance Canada
Innoviva (INVA) Holds Near $20.81 as Biopharma Royalty Stock Stays RangeboundVolatility Smile - vinanet.vn
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo Finance
HC Wainwright Issues Positive Forecast for Innoviva Earnings - MarketBeat
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com Australia
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com India
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com Canada
Three Innoviva therapies named finalists for Prix Galien award - Investing.com
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com UK
Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire
Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 69% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
How (INVA) Movements Inform Risk Allocation Models - Stock Traders Daily
Innoviva (INVA) Holds Steady at $20.68: Key Support and Resistance in FocusJelly Roll Trade - dars.gov.et
Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA? - webull.com
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo! Finance Canada
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com Nigeria
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com UK
0.58%
3.37%
자본화:
|
볼륨(24시간):